These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital. Otieno FC; Ng'ang'a L; Kariuki M East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691 [TBL] [Abstract][Full Text] [Related]
4. Clinical practice. Glycemic management of type 2 diabetes mellitus. Ismail-Beigi F N Engl J Med; 2012 Apr; 366(14):1319-27. PubMed ID: 22475595 [No Abstract] [Full Text] [Related]
5. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy. Mukherjee JJ; Majumdar S; Ray S J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486 [No Abstract] [Full Text] [Related]
6. Glycaemic control in diabetes. Herman W Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678 [No Abstract] [Full Text] [Related]
7. The glycaemic sixer [glycaemic hexad]. Kalra S J Pak Med Assoc; 2018 Oct; 68(10):1541-1542. PubMed ID: 30317360 [TBL] [Abstract][Full Text] [Related]
8. [Improvement of glycemic regulation without exogenous insulin in 40% of poorly regulated patients with type 2 diabetes mellitus; a study in 18 family practices]. Berghout LM; Gorter KJ; Rutten GE Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2035-9. PubMed ID: 11695103 [TBL] [Abstract][Full Text] [Related]
11. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Cavalot F Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513 [TBL] [Abstract][Full Text] [Related]
12. [Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough]. Reblin T; Seidel D; Stein D; Görtz A; Lander T MMW Fortschr Med; 2003 May; 145(19):41. PubMed ID: 12813977 [No Abstract] [Full Text] [Related]
13. Glycaemic control in patients with diabetes and concomitant psoriasis. Shalom G; Shapiro J; Dreiher J; Nathan A; Freud T; Comaneshter D; Horev A; Khoury R; Vinker S; Cohen AD Br J Dermatol; 2016 Aug; 175(2):428-30. PubMed ID: 26991639 [No Abstract] [Full Text] [Related]
15. The Changing Landscape of Pharmacotherapy for Diabetes Mellitus: A Review of Cardiovascular Outcomes. Wu L; Gunton JE Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766545 [TBL] [Abstract][Full Text] [Related]
16. Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real-life clinical practice. Alvarez-Guisasola F; Cebrián-Cuenca AM; Cos X; Ruiz-Quintero M; Millaruelo JM; Cahn A; Raz I; Orozco-Beltrán D; Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29271560 [TBL] [Abstract][Full Text] [Related]
17. A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society. Gunton JE; Cheung NW; Davis TM; Zoungas S; Colagiuri S; Med J Aust; 2014 Dec; 201(11):650-3. PubMed ID: 25495309 [TBL] [Abstract][Full Text] [Related]
18. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus? Zenari L; Marangoni A Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516 [TBL] [Abstract][Full Text] [Related]
19. Inspiratory muscle loading: a new approach for lowering glucose levels and glucose variability in patients with Type 2 diabetes. Corrêa AP; Figueira FR; Umpierre D; Casali KR; Schaan BD Diabet Med; 2015 Sep; 32(9):1255-7. PubMed ID: 25970646 [No Abstract] [Full Text] [Related]
20. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study. Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]